Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.
Center for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Alcohol Alcohol. 2023 Mar 10;58(2):209-215. doi: 10.1093/alcalc/agad001.
Brain-derived neurotrophic factor (BDNF) levels may be associated with alcohol use disorders (AUD) and alcohol consumption, correlate with sleep disturbance and be influenced by sex differences and sex hormones. These associations have not been examined in a single sample accounting for all these factors.
Data from 190 participants (29.4% female) with AUD were utilized. Sleep quality, craving intensity, depression, anxiety and alcohol consumption were assessed using the Pittsburgh Sleep Quality Index (PSQI), Penn Alcohol Craving Scale (PACS), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7) and Timeline Follow Back for 90 days(TLFB 90). Inventory of Drug Taking Situations (IDTS) assessed the tendency to drink in positive/negative emotional states. Serum BDNF (sBDNF) and plasma sex hormones (estrogen, progesterone, testosterone, FSH and SHBG) were measured. Pearson correlation analyses were used to examine the association between sBDNF and these measures in the entire sample and in men and women separately. Higher order interaction effects between these factors were evaluated for their association with sBDNF using a backward selection model.
No significant correlations between sBDNF levels and sex hormones, PSQI, PHQ-9, PACS, IDTS scores and alcohol consumption were found (all P-values > 0.05). sBDNF levels were negatively correlated with GAD-7 scores in men (r = -0.1841; P = 0.03). When considering all quadratic and two-way interactions among PSQI, PHQ-9, GAD-7, mean and max drinks/day, number of drinking days, heavy drinking days, and sex no higher order moderating effects of sBDNF levels were found.
Our study revealed no significant associations between sBDNF and alcohol measures, sleep, depression and sex hormones suggesting limited utility as a biomarker.
脑源性神经营养因子(BDNF)水平可能与酒精使用障碍(AUD)和酒精摄入有关,与睡眠障碍相关,并受性别差异和性激素的影响。这些关联尚未在一个考虑到所有这些因素的单一样本中进行检查。
利用 190 名 AUD 患者(29.4%为女性)的数据。使用匹兹堡睡眠质量指数(PSQI)、宾夕法尼亚酒精渴求量表(PACS)、患者健康问卷-9(PHQ-9)、广泛性焦虑障碍-7(GAD-7)和 90 天时间线回溯(TLFB 90)评估睡眠质量、渴求强度、抑郁、焦虑和酒精摄入量。药物使用情况清单(IDTS)评估了在积极/消极情绪状态下饮酒的倾向。测量血清 BDNF(sBDNF)和血浆性激素(雌激素、孕酮、睾酮、FSH 和 SHBG)。Pearson 相关分析用于检查整个样本以及男性和女性中 sBDNF 与这些测量值之间的关联。使用向后选择模型评估这些因素之间的高阶交互效应对 sBDNF 的关联。
sBDNF 水平与性激素、PSQI、PHQ-9、PACS、IDTS 评分和酒精摄入量之间没有显著相关性(所有 P 值均>0.05)。sBDNF 水平与男性的 GAD-7 评分呈负相关(r=-0.1841;P=0.03)。当考虑 PSQI、PHQ-9、GAD-7、平均和最大每日饮酒量、饮酒日数、重度饮酒日数以及性别之间的所有二次和双向交互作用时,sBDNF 水平没有发现更高阶的调节作用。
我们的研究表明,sBDNF 与酒精测量值、睡眠、抑郁和性激素之间没有显著关联,表明其作为生物标志物的应用有限。